http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57114554-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
filingDate 1981-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d790c8d87cc6fd371500ee7f7ceae6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71f1229f22c5319c54a02d517cbdd39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1677d6e0caf1d8a78579f26bd1199019
publicationDate 1982-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57114554-A
titleOfInvention N-substituted derivative of validamine, its preparation, and alpha-glucosidase inhibiting agent
abstract NEW MATERIAL:The validamine derivative of formula (Z is hydroxyl, phenoxy, thienyl, pyridyl, etc.). n EXAMPLE: N-(1,3-Dihydroxy-2-propyl)validamine. n USE: α-Glucosidase inhibiting agent. It has higher α-glucosidase inhibiting activity than validamine. Since the compound suppresses the metabolism of carbohydrates in human and other animals, it is effective to suppress the increase of the blood sugar level, and is useful as pharmaceuticals such as preventives for various diseases caused by hyperglycemia, dental caries, etc. and food additives, feed additives, etc. n PROCESS: The compound of formula is prepared by reducing a Schiff base (asomethine derivative) obtained by the reaction of validamine with a 1W10C chain aldehyde or ketone which may have substituent groups selected from OH, phenoxy, furyl, pyridyl, and cyclohexyl in a proper solvent. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012011174-A1
priorityDate 1981-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226685668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446685
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8972
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100148922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857622
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID232714

Total number of triples: 39.